Inergetics receives initial purchase order from New Marketlink for Resurgex Select

Inergetics, Inc. (OTCBB:NRTI), a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select™ from New Marketlink Pharmaceutical Corporation "New Marketlink."

The purchase order will only cover the first three months of projected sales of Resurgex Select™ under the Distribution Agreement between Inergetics (formerly Millennium Biotechnologies, Inc.) and New Marketlink, a leading distributor of pharmaceutical and healthcare products in the Philippines. New Marketlink plans to initiate a sales campaign for Resurgex Select™ following the recent Certificate of Product Registration (CPR) issued by the FDA Philippines granting permission to market the product as a nutritional supplement for cancer patients and other immune-compromised individuals throughout the country.

"This initial purchase order from New Marketlink marks the start of their distributor funded sales effort to market and sell Resurgex as a nutritional supplement for cancer patients throughout various countries in Asia and will be the first of many to come from this region of the world," stated Chairman and CEO of Inergetics Inc. Mark Mirken.

"We believe that this is the beginning of a mutually profitable relationship that will begin generating significant revenue in 2011 as New Marketlink gains further market penetration in the Philippines which would then stimulate the launch of our products in other ASEAN countries," continued Mirken.